<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2664-3243</journal-id>
<journal-title><![CDATA[Vive Revista de Salud]]></journal-title>
<abbrev-journal-title><![CDATA[Vive Rev. Salud]]></abbrev-journal-title>
<issn>2664-3243</issn>
<publisher>
<publisher-name><![CDATA[CET-BOLIVIA]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2664-32432022000200470</article-id>
<article-id pub-id-type="doi">10.33996/revistavive.v5i14.161</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Mycobacterium tuberculosis en muestras de pacientes pulmonares y extrapulmonares del Hospital Vicente Corral Moscoso]]></article-title>
<article-title xml:lang="en"><![CDATA[Mycobacterium tuberculosis in pulmonary and extrapulmonary patient samples from Vicente Corral Moscoso Hospital]]></article-title>
<article-title xml:lang="pt"><![CDATA[Mycobacterium tuberculosis em amostras de pacientes pulmonares e extrapulmonares no Hospital Vicente Corral Moscoso]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ortiz Riera]]></surname>
<given-names><![CDATA[Carlita Maribel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aspiazu Himostroza]]></surname>
<given-names><![CDATA[Karla]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pacheco Cárdenas]]></surname>
<given-names><![CDATA[Karla Estefanía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Católica de Cuenca  ]]></institution>
<addr-line><![CDATA[Cuenca ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<volume>5</volume>
<numero>14</numero>
<fpage>470</fpage>
<lpage>480</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2664-32432022000200470&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2664-32432022000200470&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2664-32432022000200470&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN La tuberculosis es una enfermedad infecciosa causada por la bacteria Mycobacterium tuberculosis cuya prevalencia a nivel mundial lejos de disminuir cada vez cobra un número mayor de morbimortalidad aunado al incremento de la resistencia bacteriana. Objetivos. Caracterizar la infección por Mycobacterium tuberculosis con las variables de estudio que presentan mayor asociación con la enfermedad: tipo de muestra, sexo biológico, origen, grupo etario, área hospitalaria, susceptibilidad a rifampicina y tipo de diagnóstico. Materiales y métodos. Estudio con enfoque cuantitativo descriptivo, documental, cuya muestra estuvo conformada por 62 aislados clínicos de Mycobacterium tuberculosis procesadas por baciloscopia, cultivo y técnicas moleculares, Hospital Vicente Corral Moscoso durante el periodo 2019-2020. Resultados. Mycobacterium tuberculosis fue más prevalente en el grupo de adultos representando el 71%, con una edad media de 47 años, predomina el sexo masculino con 75.8%, el área hospitalaria de mayor ingreso fue emergencia con 66.13%, con muestras de origen pulmonar 88.71%. Los pacientes que presentaron coinfección de tuberculosis a VIH fueron de 11.29%. El método diagnóstico más empleado fue baciloscopia con cultivo representado el 41.9%. La presencia de resistencia a rifampicina correspondiente a 13% en muestras pulmonares como extrapulmonares. Conclusiones. La tuberculosis es una enfermedad infectocontagiosa que se caracteriza por el periodo de latencia prolongado entre la infección inicial y las manifestaciones clínicas, pudiendo ser transmitido por las vías directa o indirecta. Sus altas tasas de morbimortalidad son elevadas en grupos poblacionales adultos prioritariamente del sexo masculino aunado a serie de factores de base como el tabaquismo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis whose worldwide prevalence, far from decreasing, is increasing its morbimortality, together with the increase of bacterial resistance. Objectives. To characterize Mycobacterium tuberculosis infection with the study variables that are most associated with the disease: type of sample, biological sex, origin, age group, hospital area, susceptibility to rifampicin and type of diagnosis. Materials and methods. A quantitative descriptive, documentary approach study, whose sample consisted of 62 clinical isolates of Mycobacterium tuberculosis processed by smear microscopy, culture and molecular techniques, Vicente Corral Moscoso Hospital during the period 2019-2020. Results. Mycobacterium tuberculosis was more prevalent in the adult group representing 71%, with a mean age of 47 years, male sex predominates with 75.8%, the hospital area of greatest admission was emergency with 66.13%, with samples of pulmonary origin 88.71%. The number of patients with tuberculosis/HIV coinfection was 11.29%. The most commonly used diagnostic method was smear microscopy with culture, representing 41.9%. The presence of rifampicin resistance corresponded to 13% in pulmonary and extrapulmonary samples. Conclusions. Tuberculosis is an infectious disease characterized by a long latency period between the initial infection and clinical manifestations, and can be transmitted by direct or indirect routes. Its high morbimortality rates are elevated in adult population groups, mainly males, together with a series of underlying factors such as smoking.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO A tuberculose é uma doença infecciosa causada pela bactéria Mycobacterium tuberculosis, cuja prevalência mundial, longe de diminuir, está aumentando em morbidade e mortalidade, juntamente com o aumento da resistência bacteriana. Objetivo. Para caracterizar a infecção por Mycobacterium tuberculosis com as variáveis de estudo mais associadas à doença: tipo de amostra, sexo biológico, origem, faixa etária, área hospitalar, suscetibilidade à rifampicina e tipo de diagnóstico. Materiais e métodos. Um estudo descritivo quantitativo, documental, cuja amostra consistiu de 62 isolados clínicos de Mycobacterium tuberculosis processados por microscopia de esfregaço, cultura e técnicas moleculares, Hospital Vicente Corral Moscoso durante o período de 2019-2020. Resultados. Mycobacterium tuberculosis foi mais prevalente no grupo adulto representando 71%, com uma idade média de 47 anos, predominantemente masculina com 75,8%, a área hospitalar de maior internação foi de emergência com 66,13%, com amostras de origem pulmonar 88,71%. O número de pacientes com co-infecção TB/HIV foi de 11,29%. O método de diagnóstico mais freqüentemente utilizado foi a microscopia de esfregaço com cultura, representando 41,9%. A presença de resistência à rifampicina correspondeu a 13% tanto em amostras pulmonares quanto extrapulmonares. Conclusões. A tuberculose é uma doença infecciosa caracterizada por um período prolongado de latência entre a infecção inicial e manifestações clínicas, e pode ser transmitida por vias diretas ou indiretas. Suas altas taxas de morbidade e mortalidade são altas em grupos da população adulta, principalmente homens, juntamente com uma série de fatores subjacentes, como o tabagismo.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Diagnóstico]]></kwd>
<kwd lng="es"><![CDATA[Extrapulmonar]]></kwd>
<kwd lng="es"><![CDATA[Mycobacterium tuberculosis]]></kwd>
<kwd lng="es"><![CDATA[Resistencia]]></kwd>
<kwd lng="es"><![CDATA[Rifampicina]]></kwd>
<kwd lng="en"><![CDATA[Diagnosis]]></kwd>
<kwd lng="en"><![CDATA[Extrapulmonary]]></kwd>
<kwd lng="en"><![CDATA[Mycobacterium tuberculosis]]></kwd>
<kwd lng="en"><![CDATA[Resistance]]></kwd>
<kwd lng="en"><![CDATA[Rifampicin]]></kwd>
<kwd lng="pt"><![CDATA[Diagnóstico]]></kwd>
<kwd lng="pt"><![CDATA[Extrapulmonar]]></kwd>
<kwd lng="pt"><![CDATA[Mycobacterium tuberculosis]]></kwd>
<kwd lng="pt"><![CDATA[Resistência]]></kwd>
<kwd lng="pt"><![CDATA[Rifampicina]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>OMS: Organización Mundial de la Salud</collab>
<source><![CDATA[Tuberculosis]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Ginebra-Suiza ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mbuh]]></surname>
<given-names><![CDATA[T. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Ane-Anyangwe]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Adeline]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Thumamo Pokam]]></surname>
<given-names><![CDATA[B. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Meriki]]></surname>
<given-names><![CDATA[H. D.]]></given-names>
</name>
<name>
<surname><![CDATA[Mbacham]]></surname>
<given-names><![CDATA[W. F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon]]></article-title>
<source><![CDATA[BMC. Pubmed]]></source>
<year>2019</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<collab>Ministerio de Salud Pública del Ecuador</collab>
<article-title xml:lang=""><![CDATA[Prevención, diagnóstico, tratamiento y control de la tuberculosis]]></article-title>
<source><![CDATA[Guía de Práctica Clínica]]></source>
<year>2018</year>
<edition>Segunda Edición</edition>
<publisher-loc><![CDATA[Quito ]]></publisher-loc>
<publisher-name><![CDATA[Dirección Nacional de Normatización]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="">
<collab>OPS: Organización Panamericana de la Salud</collab>
<source><![CDATA[Tuberculosis]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="">
<collab>Ministerio de Salud Pública del Ecuador</collab>
<source><![CDATA[Boletin anual de Tuberculosis]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Quito ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Migliori]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
<name>
<surname><![CDATA[Thong]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Akkerman]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Alffenaar]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Navascués]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Assao-Neino]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020]]></article-title>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>2020</year>
<volume>26</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2709-12</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Contrera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arrieta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Montano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pírez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rendimiento del GeneXpert en el diagnóstico de tuberculosis pulmonar y extrapulmonar en la edad pediátrica]]></article-title>
<source><![CDATA[Arch Pediatría Uruguay]]></source>
<year></year>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tatés-Ortega]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Ticona]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alarcón-Arrascue]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pérdida en el seguimiento de pacientes tratados por tuberculosis resistente a rifampicina o multidrogorresistente en Ecuador]]></article-title>
<source><![CDATA[Rev Panam Salud Pública]]></source>
<year>2019</year>
<volume>43</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<collab>OMS: Organización Mundial de la Salud</collab>
<source><![CDATA[Informe mundial sobre la tuberculosis 2020]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Ginebra-Suiza ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Diwan]]></surname>
<given-names><![CDATA[VK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics]]></article-title>
<source><![CDATA[Glob Health Action China]]></source>
<year>2014</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Hidalgo]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Chimoy Tuñoque]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características epidemiológicas de tuberculosis pulmonar en establecimiento penitenciario de varones de Trujillo - Perú]]></article-title>
<source><![CDATA[Acta méd]]></source>
<year>2017</year>
<volume>34</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>182-7</page-range><publisher-loc><![CDATA[Peru ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruíz-Martin Leyes]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Arzuza Ortega]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Guerra Sarmiento]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Maestre Serrano]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil de resistencia del Mycobacterium tuberculosis a fármacos antituberculosos de primera línea y sus combinaciones]]></article-title>
<source><![CDATA[Rev Cubana Med Trop]]></source>
<year>2020</year>
<month> A</month>
<day>go</day>
<volume>72</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sensibilidad a drogas de primera línea frente a cepas de M. tuberculosis del CRN Micobacterias, Guayas, 2016]]></article-title>
<source><![CDATA[Revista científica INSPILIP]]></source>
<year>2018</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<publisher-loc><![CDATA[Guayaquil, Ecuador ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="">
<collab>WMA - The World Medical Association</collab>
<source><![CDATA[Declaración de la AMM sobre las Consideraciones Eticas de las Bases de Datos de Salud y los Biobancos]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piquero Valera]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Borrego Álvarez Loida]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Presno Labrador]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Centelles Cabrera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zangroniz Piquero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comportamiento de la Tuberculosis Distrito de Salud 15D01 Ecuador durante el periodo 2005-2014]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>2016</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>224-32</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jaramillo-Grajales]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Villa]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Pabón-Gelves]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Marín-Muñoz]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Barrientos-Urdinola]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Montagut-Ferizzola]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico de tuberculosis: desde lo tradicional hasta el desarrollo actual]]></article-title>
<source><![CDATA[Med Lab]]></source>
<year>2015</year>
<volume>21</volume>
<numero>7-8</numero>
<issue>7-8</issue>
<page-range>311-32</page-range><publisher-loc><![CDATA[Colombia ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Angulo]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
<name>
<surname><![CDATA[Trejo]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Rosas]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[MEM]]></given-names>
</name>
</person-group>
<source><![CDATA[Evaluación de la prueba GeneXpert MTB/RIF en el diagnóstico rápido de la tuberculosis y de la resistencia a rifampicina en muestras extrapulmonares México 2014]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[DIQ]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[RQ]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
<name>
<surname><![CDATA[Zhingri]]></surname>
<given-names><![CDATA[NMA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tuberculosis resistente a medicamentos de primera línea en pacientes del cantón Durán, Ecuador]]></article-title>
<source><![CDATA[Rev Eugenio Espejo]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="">
<collab>Ministerio de Salud pública</collab>
<source><![CDATA[Boletin anual VIH/SIDA y Expuestos Perinatales año 2019 Ecuador]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Higuita-Gutiérrez]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Figueroa-Huertas]]></surname>
<given-names><![CDATA[ÁA]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona-Arias]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidencia de tuberculosis, VIH e Índice de Desarrollo Humano en Colombia: un análisis por departamentos 2005-2014]]></article-title>
<source><![CDATA[Infectar]]></source>
<year>2019</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>215-21</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olmos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stuardo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ramonda]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Peña]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución de la coinfección por TB/VIH en la Región Metropolitana de Chile, 2005 a 2018]]></article-title>
<source><![CDATA[Rev. méd. Chile]]></source>
<year>2020</year>
<volume>148</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>618-25</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amado Garzón]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Mercados]]></surname>
</name>
<name>
<surname><![CDATA[Martínez-Vernaza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lasso Apráez]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Lasserna Estrada]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tuberculosis extrapulmonar: un reto clínico vigente]]></article-title>
<source><![CDATA[Univ. Med]]></source>
<year>2020</year>
<volume>61</volume>
<numero>4</numero>
<issue>4</issue>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
